Related Experiment Video
Updated: Jul 6, 2026

Models of Bone Metastasis
Published on: September 4, 2012
[Role of PGE2 in bone metastatic cancer]
Masaki Inada1, Chisato Miyaura
1Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science.
Abstract:
Prostaglandin E(2) is a crucial mediator to maintain physiological homeostasis and several disease progression. In this article, we summarized the roles of PGE(2) in bone resorptive metastatic model using B16 melanoma. An antagonist of EP4, a receptor subtype for PGE(2), suppressed RANKL expression in osteoblast and following osteoclast formation that was induced by B16, suggesting cancer induced bone resorption mediate PGE(2) production in host osteoblast is a key role of cancer metastasis to bone.
Insights
Prostaglandin E(2) (PGE(2)) plays a key role in bone resorption during cancer metastasis. Blocking the EP4 receptor reduces osteoclast formation, indicating PGE(2) is crucial for bone metastasis.
Area of Science:
- Biochemistry
- Oncology
- Bone Biology
Context:
- Prostaglandin E(2) (PGE(2)) is a critical lipid mediator involved in maintaining physiological balance and disease development.
- Bone metastasis is a significant complication of cancer, leading to severe morbidity.
Purpose:
- To investigate the role of Prostaglandin E(2) (PGE(2)) in a B16 melanoma bone resorptive metastatic model.
- To elucidate the mechanism by which cancer promotes bone resorption.
Summary:
- Prostaglandin E(2) (PGE(2)) mediates bone resorption in a B16 melanoma metastasis model.
- Administration of an EP4 receptor antagonist inhibited RANKL expression in osteoblasts and subsequent osteoclast formation induced by B16 melanoma cells.
- These findings suggest that cancer-induced bone resorption involves PGE(2) production by host osteoblasts, a key mechanism in bone metastasis.
Impact:
- This study highlights Prostaglandin E(2) (PGE(2)) and its EP4 receptor as potential therapeutic targets for managing bone metastasis.
- Understanding the interplay between cancer cells and bone microenvironment can lead to novel treatment strategies.
Related Concept Videos
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Osteoclasts in Bone Remodeling
Mitogens and the Cell Cycle

